ReShape launches national advertising campaign for its flagship product, Lap-Band®

The company’s first and largest consumer advertising campaign

Featured on major TV channels and mainstream print publications

SAN CLEMENTE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (NASDAQ: RSLS), the leading physician-led weight loss and metabolic health solutions company, announced the launch of a advertising campaign using national television, print, social media and public relations to market their next-generation Lap-Band® Program with available follow-up supported by remodelingcare™, their reimbursable virtual health coaching platform to create consumer awareness and increase patient demand.

Research shows that more than 2.1 billion people, or almost 30% of the world’s population, are overweight or obese, with projections suggesting that almost half of the world’s adult population will be overweight or obese by here 20301. Additionally, the American Psychological Association recently announced the results of a February 2021 survey by The Harris Poll that found that a majority of adults (61%) reported unwanted weight changes since starting pregnancy. COVID-19 pandemic, with more than 2 in 5 (42%) reporting having gained more weight than expected2. In this group, adults reported gaining an average of 29 pounds. ReShape Lifesciences™ designed this national campaign to build awareness for the Lap-Band brand and a call to action for people looking for a personalized and effective weight loss program that puts control in the hands of the patient without drastic change in his daily lifestyle.

To view the direct-to-consumer marketing campaign elements, please access via this link: https://sincbox.gosimian.com/sp/a/FnTB0eGItGYPpjpw1b3VNQ/.

Proven by clinicians worldwide, the Lap-Band is the safest FDA-approved, minimally invasive bariatric surgery procedure, covered by most insurance plans, performed on an outpatient basis, and available on the market today. . With over two decades of data, the adjustable and reversible Lap-Band has demonstrated lower complication and mortality rates than other surgical weight loss procedures.

“In an effort to address this growing health concern regarding weight gain and to help more people achieve a better quality of life, we have invested significant time and resources in studying current test marketing programs in correlation with the historical impact of direct patient marketing on Lap-Band on patient demand.Based on these metrics, we are confident that targeted national advertising at this large scale will highlight the unique benefits of Lap- Band, generating higher procedure volumes and corresponding revenue,” commented Bart Bandy, President and CEO of ReShape Lifesciences.

National TV spots will appear in outlets such as HGTV, TLC, FOX, Bravo, etc., with print ads airing in People Magazine, Good Housekeeping, American weekly, tv guide, and other nationally selected publications. This coordinated media aims to reach people struggling to maintain a healthy weight and educate them about the benefits and accessibility of the Lap-Band procedure over other treatment options. Another campaign goal is to help people understand that the Lap-Band offers unique benefits for a variety of patients, including those with lower BMIs and women at risk of becoming pregnant.

“This is an exciting time for the company as we are able to leverage medical device and brand specific benefits nationwide unlike any other weight loss program or bariatric surgery. While we build on this impactful and comprehensive brand response advertising campaign, it can also serve as a co-marketing resource for practices to promote the Lap-Band and directly advance the growth of their consultations and procedures. said Diane Utzman-O’Neill, vice president of consumer marketing at ReShape Lifesciences.

ABOUT RESHAPE LIFESCIENCES INC.

ReShape Lifesciences™ is America’s leading weight loss and metabolic health solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® program provides a long-term, minimally invasive treatment for obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the US) laparoscopically implanted, minimally invasive medical device that wraps around the stomach, mimicking the gastric volume-reducing effect of conventional weight-loss surgery. weight. It helps to enable rapid weight loss in obese and morbidly obese patients without permanently altering the patient’s anatomy. remodelcare™ is a virtual weight management program that supports lifestyle changes for all weight loss patients, led by board-certified health coaches to help them maintain their weight over time. time. The recently launched ReShape Marketplace™ is an online collection of quality wellness products for all consumers to help them achieve their health goals.

Safe Harbor Forward-Looking Statement:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements can generally be identified by the use of words such as “expect”, “plan”, “anticipate ‘, ‘could’, ‘may’, ‘intends’, ‘will’, ‘continues’, ‘future’, other words of similar meaning and the use of future dates. The forward-looking statements in this press release include statements about our confidence that targeted national advertising on this large scale will highlight the Lap-Band’s unique advantages, generating higher procedural volumes and corresponding revenue. These forward-looking statements are based on the current expectations of our management and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied. – understood by forward-looking statements. These risks and uncertainties are described in greater detail in the Company’s filings with the Securities and Exchange Commission, in particular the factors identified as “Risk Factors” in our Annual Report on Form 10-K filed March 11, 2021. We are providing this information as of the date of this press release and undertake no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise, except as required by law. ‘required.

CONTACTS:

ReShape Lifesciences Investor Contact:
Thomas Stankovitch
Financial director
949-276-6042
[email protected]

Investor contacts:
Daniel Kontoh-Boateng
Assistant Vice President
The Ruth Group
646-536-7019
[email protected]

  1. McKinsey Global Institute, Overcoming obesity: A first economic analysis. November 2014.
    https://www.mckinsey.com/~/media/mckinsey/business%20functions/economic%20studies%20temp/our%20insights/how%20the%20world%20could%20better%20fight%20obesity/mgi_overcoming_obesity_full_report.ashx

  2. American Psychological Association, One year later: Unhealthy weight gains, increased alcohol consumption reported by Americans struggling with pandemic stress. March 2021.
    https://www.apa.org/news/press/releases/2021/03/one-year-pandemic-stress